Clipperton acted as sole financial advisor to Tilak Healthcare on its €10m growth financing led by Cap Horn and Elaia Partners, with the participation of historical investors Swen Capital Partners and iBionext Growth Fund – joined by Laboratoires Théa, the flagship of French ophthalmology – as well as Adelie, and several renowned ophthalmologists and Business Angels, including Yann Fleureau (co-founder of Cardiologs).
The funds will be used to accelerate the deployment of OdySight in France and internationally and to develop new solutions for other pathologies.
